Clinical Trial Update: Study BT7480-100 in Patients With Advanced Malignancies Associated With Nectin-4 Expression [Phase 1, Phase 2]

View source ↗

Summary

Clinical trial update on BT7480-100 in nectin-4–expressing advanced malignancies, currently in Phase 1/2 and not recruiting.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Solid Tumor

Drugs mentioned

• BT7480

Snippet

Sponsor: BicycleTx Limited | Conditions: Advanced Solid Tumor | Phase 1, Phase 2 | Status: ACTIVE_NOT_RECRUITING